한글목차

세계의 예측 진단 시장은 2030년까지 53억 달러에 달할 전망

2023년에 26억 달러로 평가된 세계의 예측 진단 시장은 2023년부터 2030년까지 CAGR 10.4%로 성장할 전망이며, 2030년에는 53억 달러에 이를 것으로 예측됩니다.

미국 시장은 7억 3,530만 달러로 추정, 중국은 CAGR 9.7%로 성장 예측

미국의 예측 진단 시장은 2023년 7억 3,530만 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2023년부터 2030년의 분석 기간에서 CAGR 9.7%로 성장을 지속하여 2030년까지 8억 480만 달러 규모에 이를 것으로 예측되고 있습니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 9.3%와 8.6%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 약 8.4%로 성장할 것으로 예측됩니다.

세계의 예측 진단 시장-주요 동향 및 촉진요인 요약

예방 헬스케어는 보다 심각한 상태로 발전하기 전에 건강 위험을 관리하기 위해 조기 발견과 예방에 중점을 둔 반응 의료에서 예방 헬스케어로의 전환을 경험합니다. 이 능동적인 접근법은 정기적인 검진, 예방 접종 및 교육 보급 활동을 포함하여 보다 건강한 인구 육성을 목표로 합니다. 특히 예측 진단은 조기에 경고를 발하고 심각한 건강 피해를 방지 현대 현대 건강 관리에 필수적입니다. 예를 들어 인도에서는 특히 II형 당뇨병과 같은 조기 발견에 의해 심부전 등의 합병증을 막을 수 있는 질환에 대해 재택 진단 검사의 인기가 급상승하고 있습니다. 마찬가지로 자궁 경부암의 HPV 검사와 유방암의 정기 검진 등 조기 암 검진은 생존율을 대폭 향상시키고 있습니다. 이러한 예방 조치는 건강상태의 개선으로 이어질 뿐만 아니라, 대규모 치료나 입원의 필요성을 최소한으로 억제함으로써 경제적 부담도 경감합니다.

기술의 진보는 예방 의료를 보다 효율적이고 광범위하게 만들고 있습니다. 인공지능(AI)과 머신러닝(ML)은 진단 정확도를 높이고 심장병과 알츠하이머병과 같은 질병의 조기 발견을 가능하게 합니다. FDA(미국 식품의약국)는 AI 기반 진단 툴의 암 식별 정확도를 높이 평가하고 있으며, 특히 자원이 제한된 환경에서 헬스케어 제공을 개선할 가능성을 부각하고 있습니다. 또한 건강 관리 조직은 ML과 고급 분석을 활용하여 업무 효율성과 환자 관리를 강화하는 인사이트를 끌어내는 예측 분석을 통해 엄청난 데이터 풀을 활용할 수 있게 되었습니다. 이 접근법은 질병의 예방과 관리에 도움이 되며 질병 진행을 예측하고 조기 개입을 촉진함으로써 환자의 결과를 개선합니다. 사물인터넷(IoT) 기술은 환자의 건강 상태를 실시간으로 모니터링하고 병리의 악화를 막는 적시에 의료 개입을 가능하게 함으로써 이를 더욱 강화합니다.

이러한 장점이 있음에도 불구하고 예측 진단 및 조기 발견 기술의 채택은 수요 확립, 이점에 대한 환자 교육, 이러한 혁신에 대한 재정적 및 규제적 지원 확보와 같은 문제에 직면해 있습니다. 이러한 장애에 대처하기 위해 건강 관리 조직은 철저한 시장 조사를 수행하고 전략적 파트너십을 형성하며 연구개발에 투자해야 합니다. 예방 헬스케어의 범위를 넓히기 위해서는 지적재산의 보호와 신기술을 기존의 헬스케어 시스템에 통합하는 것도 필수적입니다. 예측 진단의 광범위한 도입은 예방과 조기 개입에 초점을 맞춘 건강 관리의 대변혁을 말하는 것입니다. 이 접근법은 헬스케어 비용 절감을 목표로 할 뿐만 아니라 삶의 질을 높이고 세계 헬스케어 시스템의 탄력적인 미래를 위한 기초가 됩니다.

조사 대상 기업 예(총 47건)

• Abbott Molecular
• Almac Group Ltd.
• Ambry Genetics Corp.
• BioGenex
• Epistem Ltd.
• Epistem Ltd.
• MDxHEALTH Inc.
• Myriad Genetics Inc.
• OPKO Health, Inc.
• Prometheus Laboratories Inc.
• QIAGEN NV

목차

제1장 조사 방법

제2장 주요 요약

• 시장 개요
• 주요 기업
• 시장 동향 및 촉진요인
• 세계 시장 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 기타 유럽
• 아시아태평양
• 세계 기타 지역

제4장 경쟁

영문목차

Global Predictive Diagnostics Market to Reach US$5.3 Billion by 2030

The global market for Predictive Diagnostics estimated at US$2.6 Billion in the year 2023, is expected to reach US$5.3 Billion by 2030, growing at a CAGR of 10.4% over the analysis period 2023-2030.

The U.S. Market is Estimated at US$735.3 Million While China is Forecast to Grow at 9.7% CAGR

The Predictive Diagnostics market in the U.S. is estimated at US$735.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$804.8 Million by the year 2030 trailing a CAGR of 9.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.3% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Global Predictive Diagnostics Market - Key Trends and Drivers Summarized

Preventive healthcare is experiencing a transformative shift from reactive to proactive medical practices, emphasizing early detection and prevention to manage health risks before they develop into more severe conditions. This proactive approach includes regular screenings, vaccinations, and educational outreach, aimed at fostering a healthier population. Preventive screenings, in particular, have become an integral part of modern healthcare, offering early warnings and preventing serious health outcomes. For instance, in India, the popularity of home-diagnostic tests is surging, particularly for conditions like Type II diabetes where early detection can prevent complications such as heart failure. Similarly, early cancer screenings, like HPV tests for cervical cancer and routine checks for breast cancer, have significantly improved survival rates. These preventive measures not only lead to better health outcomes but also reduce the economic burden by minimizing the need for extensive treatments and hospitalizations.

Technological advancements are making preventive care more efficient and widespread. Artificial intelligence (AI) and machine learning (ML) are enhancing diagnostic accuracy, enabling earlier detection of diseases such as heart conditions and Alzheimer’s. The FDA has recognized AI-based diagnostic tools for their precision in identifying cancer, which highlights their potential to improve healthcare delivery, especially in resource-limited environments. Additionally, healthcare organizations are increasingly leveraging vast data pools through predictive analytics, which utilizes ML and advanced analytics to extract insights that enhance operational efficiency and patient care. This approach helps in disease prevention and management, improving patient outcomes by predicting disease progression and facilitating early intervention. The Internet of Things (IoT) technology further augments this by allowing real-time monitoring of patient health, enabling timely medical interventions that prevent conditions from worsening, thus reducing hospital visits and enhancing overall patient outcomes.

Despite the benefits, the adoption of predictive diagnostics and early detection technologies faces challenges such as establishing demand, educating patients on the benefits, and securing financial and regulatory support for these innovations. To address these obstacles, healthcare organizations need to conduct thorough market research, form strategic partnerships, and invest in research and development. Protecting intellectual property and integrating new technologies into existing healthcare systems are also vital for expanding the scope of preventive healthcare. The broader adoption of predictive diagnostics heralds a major transformation in healthcare, focusing on prevention and early intervention. This approach not only aims to reduce healthcare costs but also enhances the quality of life, setting a foundation for a resilient future in global healthcare systems.

Select Competitors (Total 47 Featured) -

• Abbott Molecular
• Almac Group Ltd.
• Ambry Genetics Corp.
• BioGenex
• Epistem Ltd.
• Epistem Ltd.
• MDxHEALTH Inc.
• Myriad Genetics Inc.
• OPKO Health, Inc.
• Prometheus Laboratories Inc.
• QIAGEN N.V.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Predictive Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Advances in AI and Machine Learning Propel Growth in Predictive Diagnostics
  • Increasing Healthcare Data Availability Expands Addressable Market Opportunity
  • Rising Incidence of Chronic Diseases Throws the Spotlight on Predictive Diagnostics
  • Growing Emphasis on Preventive Healthcare Generates Demand for Predictive Solutions
  • Integration with Electronic Health Records (EHR) Spurs Adoption
  • Personalized Medicine Trends Sustain Growth in Predictive Diagnostic Tools
  • Big Data Analytics Advances Propel Growth in Predictive Healthcare Solutions
  • Cloud Computing Innovations Expand Addressable Market for Predictive Diagnostics
  • Improved Patient Outcomes through Early Detection Strengthens Business Case for Predictive Diagnostics
  • AI-driven Predictive Models Generate Demand for Advanced Diagnostic Tools
  • Real-time Monitoring and Predictive Analytics Propel Growth in Patient Care Management
  • Innovations in Biomarker Discovery Generate Opportunities for Predictive Diagnostics
  • Integration with IoT Devices in Healthcare Propels Growth of Predictive Solutions
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Predictive Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Predictive Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Predictive Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 5: USA Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 6: USA Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• CANADA
  • TABLE 7: Canada Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 8: Canada Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• JAPAN
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 9: Japan Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 10: Japan Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• CHINA
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 11: China Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 12: China Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• EUROPE
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 13: Europe Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 14: Europe Historic Review for Predictive Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 15: Europe 16-Year Perspective for Predictive Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
• FRANCE
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 16: France Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 17: France Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• GERMANY
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 18: Germany Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 19: Germany Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• ITALY
  • TABLE 20: Italy Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 21: Italy Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• UNITED KINGDOM
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 22: UK Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 23: UK Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• REST OF EUROPE
  • TABLE 24: Rest of Europe Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 25: Rest of Europe Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• ASIA-PACIFIC
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 26: Asia-Pacific Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Asia-Pacific Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• REST OF WORLD
  • TABLE 28: Rest of World Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 29: Rest of World Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

IV. COMPETITION